Cargando…
Flare of Antiphospholipid Syndrome in the Course of COVID-19
We report the case of a 48-year-old man followed since 2013 for primary antiphospholipid syndrome (APLS) revealed by venous thromboembolism in the presence of antiphospholipid antibodies (APL-Abs, anticardiolipin and anti-β-2-glycoprotein-1), who decompensated in the course of coronavirus disease (C...
Autores principales: | Maria, Alexandre Thibault Jacques, Diaz-Cau, Isabelle, Benejean, Jean-Marc, Nutz, Anaïs, Schiffmann, Aurélie, Biron-Andreani, Christine, Guilpain, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486139/ https://www.ncbi.nlm.nih.gov/pubmed/32935073 http://dx.doi.org/10.1055/s-0040-1716735 |
Ejemplares similares
-
Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis
por: Fornero, Léa, et al.
Publicado: (2023) -
The Flare Up of Catastrophic Antiphospholipid Syndrome: a Report of an Immunosuppressive Withdrawal-Induced Case
por: Mortazavimoghaddam, Sayyed Gholamreza
Publicado: (2011) -
Idiopathic purpura fulminans associated with anti-protein S antibodies in children: a multicenter case series and systematic review
por: Theron, Alexandre, et al.
Publicado: (2022) -
Lung Fibrosis Is Improved by Extracellular Vesicles from IFNγ-Primed Mesenchymal Stromal Cells in Murine Systemic Sclerosis
por: Rozier, Pauline, et al.
Publicado: (2021) -
Antiphospholipid antibodies and thrombosis: pathogenesis of antiphospholipid syndrome
por: Koike, T
Publicado: (2003)